Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex i sensing

64Citations
Citations of this article
78Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Quantum dots (QDs) have attracted increasing interest in bioimaging and sensing. Here, we report a biosensor of complex I using ubiquinone-terminated disulphides with different alkyl spacers (Qn NS, n = 2, 5 and 10) as surface-capping ligands to functionalise CdSe/ZnS QDs. The enhancement or quenching of the QD bioconjugates fluorescence changes as a function of the redox state of Qn NS, since QDs are highly sensitive to the electron-transfer processes. The bioconjugated Qn NS-QDs emission could be modulated by complex I in the presence of NADH, which simulates an electron-transfer system part of the mitochondrial respiratory chain, providing an in vitro and intracellular complex I sensor. Epidemiological studies suggest that Parkinson's patients have the impaired activity of complex I in the electron-transfer chain of mitochondria. We have demonstrated that the Q n NS-QDs system could aid in early stage Parkinson's disease diagnosis and progression monitoring by following different complex I levels in SH-SY5Y cells.

Cite

CITATION STYLE

APA

Ma, W., Qin, L. X., Liu, F. T., Gu, Z., Wang, J., Pan, Z. G., … Long, Y. T. (2013). Ubiquinone-quantum dot bioconjugates for in vitro and intracellular complex i sensing. Scientific Reports, 3. https://doi.org/10.1038/srep01537

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free